Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06619353
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-23
Brief Title:
RCVR Residual CardioVascular Risk Prospective Multicenter Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Residual CardioVascular Risk RCVR After Percutaneous Coronary Intervention a Prospective Multicenter Study
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RCVR
Brief Summary:
The observational study aims to evaluate the long-term effects of residual cardiovascular risk on clinical outcomes following percutaneous coronary intervention PCI This risk includes thrombotic metabolic inflammatory and procedural factors which are assessed 1 month after the intervention The primary question the study seeks to answer is
What residual cardiovascular risk affects long-term clinical outcomes in patients undergoing PCI
Participants will undergo artificial intelligence-based quantitative coronary analysis after PCI and will have comprehensive laboratory tests conducted at 1 month to evaluate residual cardiovascular risk and then annually for 3 years post-intervention to assess changes in this risk
What residual cardiovascular risk affects long-term clinical outcomes in patients undergoing PCI
Participants will undergo artificial intelligence-based quantitative coronary analysis after PCI and will have comprehensive laboratory tests conducted at 1 month to evaluate residual cardiovascular risk and then annually for 3 years post-intervention to assess changes in this risk
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None